Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...
EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...
EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC, including sample size ...
As the flagship oncology journal under Sage Publishing, TAMO strives to publish research of significant value to oncology research and clinical practice. It covers clinical trials and real-world ...
A new international online survey published in the Journal of Affective Disorders gives voice to the lived experiences of ...
BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ ...
A data-minimizing way to research health data is Secure Multiparty Computation. On the successful implementation of the ...
A review indicates that probiotic, prebiotic, and synbiotic supplements could be beneficial for skin health, especially for managing conditions such as eczema.
Shares in Ultragenyx and Mereo BioPharma have plunged after their drug for osteogenesis imperfecta (OI) or brittle bone ...
Tea may offer powerful health benefits, but how it is prepared and consumed matters. Tea has a long history as both a ...
Coffee is one of the most widely consumed psychoactive substances on the planet, yet despite more than two billion cups being ...
Pharmaceutical Technology on MSN
Enriched patient data needed to uncover sex differences in Alzheimer’s trials
Data indicating unequal treatment effects in women has prompted calls for more nuance in Alzheimer’s diagnosis and drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback